标题
Pemphigus: Current and Future Therapeutic Strategies
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-06-25
DOI
10.3389/fimmu.2019.01418
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti-CD 20 monoclonal antibodies
- (2019) S.G. Kwatra et al. BRITISH JOURNAL OF DERMATOLOGY
- Mucosal involvement is a risk factor for poor clinical outcomes and relapse in patients with pemphigus treated with rituximab
- (2019) Soo Ick Cho et al. Dermatologic Therapy
- Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
- (2019) Pavlina Chuntova et al. Frontiers in Immunology
- CAR T-cells: costs, comparisons, and commentary
- (2019) Annette E. Hay et al. JOURNAL OF MEDICAL ECONOMICS
- Prevalence Estimates for Pemphigus in the United States
- (2019) Sara Wertenteil et al. JAMA Dermatology
- Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disorders
- (2019) Anca Prica et al. LEUKEMIA & LYMPHOMA
- Real-world effectiveness and safety of rituximab in the treatment of rheumatoid arthritis: A single-center experience in Taiwan
- (2019) Kai-Chun Wang et al. International Journal of Rheumatic Diseases
- Chimeric Antigen Receptor T-Cells: The Future is Now
- (2019) Wassim Mchayleh et al. Journal of Clinical Medicine
- Pharmacological advances in pemphigoid
- (2019) Roberto Maglie et al. CURRENT OPINION IN PHARMACOLOGY
- Chimeric antigen receptor–modified T cells: CD19 and the road beyond
- (2018) Alexander I. Salter et al. BLOOD
- Translating anti-CD19 CAR T-Cell therapy into clinical practice for relapsed/refractory diffuse large B-Cell lymphoma
- (2018) Victor A. Chow et al. BLOOD
- New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
- (2018) Saskia Meyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab-induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti-rituximab antibodies
- (2018) Chiara Vendramin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches
- (2018) Robert Pollmann et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
- (2018) Ho So et al. CLINICAL RHEUMATOLOGY
- A novel lateral flow immunoassay for the rapid detection of anti-Dsg3 IgG serum autoantibodies in pemphigus vulgaris
- (2018) Thomas Schmidt et al. EXPERIMENTAL DERMATOLOGY
- Pemphigus group: overview, epidemiology, mortality, and comorbidities
- (2018) Khalaf Kridin IMMUNOLOGIC RESEARCH
- Rituximab in pemphigus
- (2018) Vivien Hebert et al. Immunotherapy
- Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab
- (2018) Yuta Ito et al. INTERNAL MEDICINE
- Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review
- (2018) Soheil Tavakolpour et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- T H 1/T H 17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus
- (2018) Thomas Schmidt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center
- (2018) Keshavamurthy Vinay et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- (2018) Elana Putterman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts
- (2018) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Rituximab Treatment Of Pemphigus Foliaceus- A Retrospective Study Of 12 Patients
- (2018) Irene Palacios-Álvarez et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab
- (2018) Marwah Adly Saleh JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ofatumumab for TTP in a Patient with Anaphylaxis Associated with Rituximab
- (2018) Maeve P. Crowley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy: A feasibility strategy for CAR‑T cell therapy in the treatment of solid tumors (Review)
- (2018) Jinjing Xu et al. Oncology Letters
- Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients
- (2018) Kai-Che Wei et al. Scientific Reports
- Emerging treatment options for the management of pemphigus vulgaris
- (2018) Khalaf Kridin Therapeutics and Clinical Risk Management
- B Cell Modulation Strategies in Autoimmune Diseases: New Concepts
- (2018) Philippe Musette et al. Frontiers in Immunology
- Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions
- (2018) Mauro Alaibac Frontiers in Immunology
- Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus
- (2018) Roberta Lotti et al. Frontiers in Immunology
- Humoral Epitope Spreading in Autoimmune Bullous Diseases
- (2018) Dario Didona et al. Frontiers in Immunology
- Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
- (2018) Timothy M. Pierpont et al. Frontiers in Oncology
- Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus
- (2018) Kyle T. Amber et al. AUTOIMMUNITY REVIEWS
- Tofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigus
- (2018) Soheil Tavakolpour Dermatologic Therapy
- Targeted Therapies for Autoimmune Bullous Diseases: Current Status
- (2018) Kyle T. Amber et al. DRUGS
- Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
- (2018) Peter Ulrichts et al. JOURNAL OF CLINICAL INVESTIGATION
- Research Techniques Made Simple: CAR T Cell Therapy
- (2018) Haziq F. Siddiqi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Investigation of the predisposing factor of pemphigus and its clinical subtype through a genome-wide association and next generation sequence analysis
- (2018) Y. Sun et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin
- (2018) John MacIsaac et al. TRANSFUSION
- Targeting FcRn to Generate Antibody-Based Therapeutics
- (2018) E. Sally Ward et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid
- (2018) Alex Kaye et al. JAMA Dermatology
- Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
- (2018) Maxi Hofrichter et al. Frontiers in Immunology
- The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris—Analysis of Four Different Ethnic Cohorts
- (2018) Andreas Recke et al. Frontiers in Immunology
- Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
- (2018) Noelle Frey et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical and immunological features of pemphigus relapse
- (2018) I. Ujiie et al. BRITISH JOURNAL OF DERMATOLOGY
- CAR-T cell therapy in melanoma: A future success story?
- (2018) Bianca Simon et al. EXPERIMENTAL DERMATOLOGY
- Bullous autoimmune dermatoses
- (2018) Silke C. Hofmann et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Persistent B Lymphocyte Depletion After an Ultralow Dose of Rituximab for Pemphigus Vulgaris
- (2018) A Lazzarotto et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Assessment of serious infections in pemphigus and pemphigoid by a national registry
- (2018) R. Maglie et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
- (2018) Sophie Viaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
- (2018) Kristen B. Long et al. Frontiers in Immunology
- Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
- (2018) Qunfang Zhang et al. Frontiers in Immunology
- Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus
- (2017) Swantje Mindorf et al. EXPERIMENTAL DERMATOLOGY
- Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE)
- (2017) William Stohl Expert Review of Clinical Immunology
- The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status
- (2017) Anna Vidal-Crespo et al. HAEMATOLOGICA
- Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities
- (2017) Anja Wegner Immunotherapy
- Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?
- (2017) Soheil Tavakolpour INTERNATIONAL IMMUNOPHARMACOLOGY
- Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge
- (2017) Roberto Maglie et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy
- (2017) Shin Lee et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy
- (2017) Giovanni Paolino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FDA Approval of Tisagenlecleucel
- (2017) Peter B. Bach et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- New development in CAR-T cell therapy
- (2017) Zhenguang Wang et al. Journal of Hematology & Oncology
- Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis
- (2017) Huijie Yuan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab
- (2017) Lauren N. Albers et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab
- (2017) C. Baykal et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Fatal infection of Pneumocystis jiroveci pneumonia in a pemphigus patient treated with rituximab
- (2017) K.C. Wei et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
- (2017) Pascal Joly et al. LANCET
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data
- (2017) Jean-Hugues Salmon et al. RHEUMATOLOGY
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Evaluating the Efficacy of Double-Filtration Plasmapheresis in Treating Five Patients With Drug-Resistant Pemphigus
- (2017) Takaaki Higashihara et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation
- (2017) Y.-M. Lu et al. TRANSPLANTATION PROCEEDINGS
- The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status
- (2017) Anna Vidal-Crespo et al. HAEMATOLOGICA
- Mechanisms of Autoantibody-Induced Pathology
- (2017) Ralf J. Ludwig et al. Frontiers in Immunology
- Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review
- (2017) Amy S. Levin et al. Journal of Allergy and Clinical Immunology-In Practice
- Pemphigus
- (2017) Michael Kasperkiewicz et al. Nature Reviews Disease Primers
- Rituximab-Induced Serum Sickness–Like Reaction
- (2016) Farah Succaria et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Management of pemphigus disease in pregnancy
- (2016) Soheil Tavakolpour et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist
- (2016) David A. Khan ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica
- (2016) Karen C. Broussard et al. CLINICS IN DERMATOLOGY
- A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections
- (2016) Narges Seyfizadeh et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?
- (2016) Venkat Reddy et al. DRUG DISCOVERY TODAY
- Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris
- (2016) Thomas Schmidt et al. EXPERIMENTAL DERMATOLOGY
- The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy
- (2016) Leslie J. Crofford et al. Expert Review of Clinical Immunology
- The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus
- (2016) KyleT Amber et al. Indian Journal of Dermatology Venereology & Leprology
- Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study
- (2016) VinodKumar Sharma et al. Indian Journal of Dermatology Venereology & Leprology
- First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up
- (2016) A. Razzaque Ahmed et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhanced Expression of Bruton’s Tyrosine Kinase in B Cells Drives Systemic Autoimmunity by Disrupting T Cell Homeostasis
- (2016) Odilia B. J. Corneth et al. JOURNAL OF IMMUNOLOGY
- Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients
- (2016) Atsunari Tsuchisaka et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany
- (2016) Franziska Hübner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rituximab-induced Cytokine Storm in the Absence of Overt Lymphoproliferative Disease
- (2016) Mark Williams et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells
- (2016) R. Velmurugan et al. MOLECULAR CANCER THERAPEUTICS
- Precision medicine for autoimmune disease
- (2016) Lucienne Chatenoud NATURE BIOTECHNOLOGY
- CAR-T cells take aim at autoimmunity
- (2016) Alexandra Flemming NATURE REVIEWS DRUG DISCOVERY
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- Loss of flotillin expression results in weakened desmosomal adhesion and Pemphigus vulgaris-like localisation of desmoglein-3 in human keratinocytes
- (2016) Frauke Völlner et al. Scientific Reports
- Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene
- (2016) Dan Vodo et al. PLoS Genetics
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
- (2016) E. Zah et al. Cancer Immunology Research
- Systemic lupus erythematosus
- (2016) Arvind Kaul et al. Nature Reviews Disease Primers
- Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus
- (2016) Tina Hennerici et al. PLoS One
- Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens
- (2015) H Wang et al. ACTA DERMATO-VENEREOLOGICA
- IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects
- (2015) Danka Svecova AUSTRALASIAN JOURNAL OF DERMATOLOGY
- A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab
- (2015) A. Razzaque Ahmed et al. AUTOIMMUNITY REVIEWS
- Rituximab therapy in pemphigus foliaceus: report of 12 cases and review of recent literature
- (2015) L. de Sena Nogueira Maehara et al. BRITISH JOURNAL OF DERMATOLOGY
- Paradoxical worsening of pemphigus vulgaris following rituximab therapy
- (2015) R.J. Feldman BRITISH JOURNAL OF DERMATOLOGY
- Ofatumumab in the treatment of non-Hodgkin’s lymphomas
- (2015) Lionel Karlin et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Molekulare Diagnostik der blasenbildenden Autoimmundermatosen
- (2015) K. Hoffmann et al. HAUTARZT
- Gastric Cancer and Paraneoplastic Pemphigus
- (2015) Norwani Basir et al. Indian Journal of Surgery
- S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid
- (2015) Rüdiger Eming et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris
- (2015) Yumay Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Large-Scale Electron Microscopy Maps of Patient Skin and Mucosa Provide Insight into Pathogenesis of Blistering Diseases
- (2015) Ena Sokol et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The role of adjuvant therapy in pemphigus: A systematic review and meta-analysis
- (2015) Lihi Atzmony et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Successful use of etanercept in a case of toxic epidermal necrolysis induced by rituximab
- (2015) D. Didona et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-Term Remissions in Recalcitrant Pemphigus Vulgaris
- (2015) A. Razzaque Ahmed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus
- (2015) Shane Kelly et al. PATHOLOGY
- Rituximab-induced serum sickness: A systematic review
- (2015) Paras Karmacharya et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- First-line Treatment of Pemphigus Vulgaris With a Combination of Rituximab and High-Potency Topical Corticosteroids
- (2015) Saskia Ingen-Housz-Oro et al. JAMA Dermatology
- Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris
- (2015) Keshavamurthy Vinay et al. JAMA Dermatology
- Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses
- (2014) P.J. Keith et al. BRITISH JOURNAL OF DERMATOLOGY
- 150thAnniversary Series: Desmosomes and Autoimmune Disease, Perspective of Dynamic Desmosome Remodeling and Its Impairments in Pemphigus
- (2014) Yasuo Kitajima CELL COMMUNICATION AND ADHESION
- Molecular Diagnosis in Autoimmune Skin Blistering Conditions
- (2014) J.V. Otten et al. CURRENT MOLECULAR MEDICINE
- Pilot Study of 19 Patients with Severe Pemphigus: Prophylactic Treatment with Rituximab Does Not Appear to be Beneficial
- (2014) S. Gregoriou et al. DERMATOLOGY
- Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins
- (2014) Jana Langenhan et al. EXPERIMENTAL DERMATOLOGY
- Novel System Evaluating In Vivo Pathogenicity of Desmoglein 3-Reactive T Cell Clones Using Murine Pemphigus Vulgaris
- (2014) H. Takahashi et al. JOURNAL OF IMMUNOLOGY
- Involvement of the Apoptotic Mechanism in Pemphigus Foliaceus Autoimmune Injury of the Skin
- (2014) N. Li et al. JOURNAL OF IMMUNOLOGY
- Pemphigus Vulgaris IgG Directly Inhibit Desmoglein 3-Mediated Transinteraction
- (2014) W.-M. Heupel et al. JOURNAL OF IMMUNOLOGY
- Pathogenic IgG Antibodies against Desmoglein 3 in Pemphigus Vulgaris Are Regulated by HLA-DRB1*04:02–Restricted T Cells
- (2014) Rüdiger Eming et al. JOURNAL OF IMMUNOLOGY
- No Evidence of Apoptotic Cells in Pemphigus Acantholysis
- (2014) Ineke C. Janse et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rapid transition from pemphigus vulgaris to pemphigus foliaceus
- (2014) T. Ito et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
- (2014) M. Hertl et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
- (2014) K.T. Amber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Desmosomes and Extradesmosomal Adhesive Signaling Contacts in Pemphigus
- (2014) Jens Waschke et al. MEDICINAL RESEARCH REVIEWS
- Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris
- (2014) Christoph T. Ellebrecht et al. JAMA Dermatology
- Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol
- (2014) Kara Heelan et al. JAMA Dermatology
- Concurrent Cytomegalovirus and Herpes Simplex Virus Infection in Pemphigus Vulgaris Treated with Rituximab and Prednisolone
- (2013) H Chiu et al. ACTA DERMATO-VENEREOLOGICA
- Clearance Efficacy of Autoantibodies in Double Filtration Plasmapheresis for Pemphigus Foliaceus
- (2013) A Kasuya et al. ACTA DERMATO-VENEREOLOGICA
- A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab
- (2013) Y. A. Leshem et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients
- (2013) K.D. Tran et al. BRITISH JOURNAL OF DERMATOLOGY
- Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris
- (2013) V. K. Sharma et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Autoimmune blistering dermatoses as systemic diseases
- (2013) Snejina Vassileva et al. CLINICS IN DERMATOLOGY
- Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris
- (2013) Kyle T. Amber et al. EXPERIMENTAL DERMATOLOGY
- Delayed Topical p38 MAPK Inhibition Attenuates Full-Thickness Burn Wound Inflammatory Signaling
- (2013) Damien Carter et al. Journal of Burn Care & Research
- MAPKAP Kinase 2 (MK2)-Dependent and -Independent Models of Blister Formation in Pemphigus Vulgaris
- (2013) Xuming Mao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication
- (2013) M. Kolesnik et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
- (2013) N. Colliou et al. Science Translational Medicine
- Mechanism of action of therapeutic monoclonal antibodies: Promises and pitfalls of in vitro and in vivo assays
- (2012) Josée Golay et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Adjuvant Rituximab Therapy of Pemphigus
- (2012) Luisa Lunardon et al. ARCHIVES OF DERMATOLOGY
- Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: A preliminary prospective randomized controlled study
- (2012) AmrinderJ Kanwar et al. Indian Journal of Dermatology Venereology & Leprology
- Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases
- (2012) Michael Kasperkiewicz et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigus
- (2012) Luisa Lunardon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface
- (2012) Giovanni Di Zenzo et al. JOURNAL OF CLINICAL INVESTIGATION
- CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
- (2012) Moa Fransson et al. Journal of Neuroinflammation
- Topical sirolimus for oral pemphigus vulgaris: 3 unresponsive cases
- (2012) Angelique M. Poot et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up
- (2012) Giuseppe Cianchini et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients
- (2012) Yael A. Leshem et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris
- (2012) C. Chams-Davatchi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pathogenicity of Autoantibodies in Anti-p200 Pemphigoid
- (2012) Katerina Vafia et al. PLoS One
- Signaling Dependent and Independent Mechanisms in Pemphigus Vulgaris Blister Formation
- (2012) Masataka Saito et al. PLoS One
- Immunoadsorption in Dermatology
- (2012) Damian Meyersburg et al. THERAPEUTIC APHERESIS AND DIALYSIS
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis
- (2011) D.A.M. Oktarina et al. BRITISH JOURNAL OF DERMATOLOGY
- British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011
- (2011) S.J. Meggitt et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients
- (2011) M. Kasperkiewicz et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy
- (2011) R.J. Feldman et al. BRITISH JOURNAL OF DERMATOLOGY
- Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris
- (2011) M. Behzad et al. BRITISH JOURNAL OF DERMATOLOGY
- Immunosuppressive therapy for autoimmune bullous diseases
- (2011) Michael Meurer CLINICS IN DERMATOLOGY
- Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies
- (2011) David I Hong et al. Expert Review of Clinical Immunology
- Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris
- (2011) T. Yokoyama et al. INTERNATIONAL IMMUNOLOGY
- Paraneoplastic autoimmune multiorgan syndrome: 20 years after
- (2011) Annette Czernik et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Autoimmune bullous skin diseases. Part 2: diagnosis and therapy
- (2011) Andrea Kneisel et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Autoimmune bullous skin diseases. Part 1: Clinical manifestations
- (2011) Andrea Kneisel et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Desmoglein as a Target in Skin Disease and Beyond
- (2011) Masayuki Amagai et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sirolimus for acute pemphigus vulgaris: A case report and discussion of dualistic action providing for both immunosuppression and keratinocyte protection
- (2011) Sergei A. Grando et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus
- (2011) Linda K. Martin et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of rituximab treatment in Indian pemphigus patients
- (2011) A.J. Kanwar et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Direct Effect of Rituximab in B-Cell-Derived Lymphoid Neoplasias: Mechanism, Regulation, and Perspectives
- (2011) C. Bezombes et al. MOLECULAR CANCER RESEARCH
- Association Between Cancer and Immunosuppressive Therapy—Analysis of Selected Studies in Pemphigus and Pemphigoid
- (2010) Dalia Mabrouk et al. ANNALS OF PHARMACOTHERAPY
- Immunoadsorption in dermatology
- (2010) Enno Schmidt et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
- (2010) Alina Sesarman et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The prevalence of 30 ICD-10 autoimmune diseases in Denmark
- (2010) William W. Eaton et al. IMMUNOLOGIC RESEARCH
- Clinical and immunopathological spectrum of paraneoplastic pemphigus
- (2010) Jutta Zimmermann et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- p38MAPK Signaling and Desmoglein-3 Internalization Are Linked Events in Pemphigus Acantholysis
- (2010) Puneet S. Jolly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p38 MAPK Activation Is Downstream of the Loss of Intercellular Adhesion in Pemphigus Vulgaris
- (2010) Xuming Mao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial
- (2010) Stefan Beissert et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study
- (2010) G Chaidemenos et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pemphigus vegetans: a clinical, histological, immunopathological and prognostic study
- (2010) I. Zaraa et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Rituximab in Severe Pemphigus
- (2009) Enno Schmidt et al. Annals of the New York Academy of Sciences
- Apoptosis in pemphigus
- (2009) Enno Schmidt et al. AUTOIMMUNITY REVIEWS
- Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3
- (2009) Angela Nagel et al. CLINICAL IMMUNOLOGY
- Involvement of TH1/TH2 Cytokines in the Pathogenesis of Autoimmune Skin Disease—Pemphigus Vulgaris
- (2009) Abhigyan Satyam et al. IMMUNOLOGICAL INVESTIGATIONS
- Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris
- (2009) Sujay Khandpur et al. Indian Journal of Dermatology Venereology & Leprology
- Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome
- (2009) Virendra N. Sehgal et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- B-Cell-Directed Therapy for Inflammatory Skin Diseases
- (2009) Angela Nagel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris
- (2009) Angela Nagel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mycophenolate mofetil in dermatology
- (2009) Alissa K. Orvis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for pemphigus
- (2009) Masayuki Amagai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Multicenter Randomized, Double-blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris
- (2008) Victoria P. Werth et al. ARCHIVES OF DERMATOLOGY
- Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus
- (2008) Pamela Vezzoli et al. Expert Review of Clinical Immunology
- Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases
- (2008) Michael Hertl et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: A paradigm of human autoimmunity
- (2008) Donna A. Culton et al. JOURNAL OF AUTOIMMUNITY
- Rituximab Exerts a Dual Effect in Pemphigus Vulgaris
- (2008) Rüdiger Eming et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses
- (2008) Hugo Mouquet et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Disruption of Desmosome Assembly by Monovalent Human Pemphigus Vulgaris Monoclonal Antibodies
- (2008) Xuming Mao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells
- (2008) Nancy A. Goebl et al. MOLECULAR BIOLOGY OF THE CELL
- Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome
- (2008) Fabien MALDONADO et al. RESPIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started